Trade Mark Journal No.2026/011 13 March 2026
UK00004347756 2 March 2026 (42)
OPTIMISM
International priority date claimed: 10 October 2025
(United States of America)
(99436273)
- Class 42
- Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals that treat systemic mastocytosis.
Telios Pharma Inc.
Representative: Morgan, Lewis & Bockius UK LLP